Clinical Trial Update: A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 safety, tolerability, and efficacy study of TransCon hGH in children with growth hormone deficiency has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency Pediatric

Drugs mentioned

• TransCon hGH (somatropin)

Snippet

Sponsor: Ascendis Pharma Endocrinology Division A/S | Conditions: Growth Hormone Deficiency, Pediatric, Endocrine System Diseases | Phase 3 | Status: COMPLETED | Results posted: 2022-01-04